ISPOR Europe Research Poster:

Access to Coverage with Evidence Development Schemes for Medical Devices and Procedures in England, France, Germany, Spain, and the USA

AuthorsHeather WellamMichelle JamesKimrin PannuHelena GrantClare FoyAdam Brown

PresenterAdam Brown

Presentation Time: Tuesday 19th November, 10.30am–1.30pm

In this short video, Heather Wellam (Senior Consultant – Market Access) introduces the research:

Request a copy of our poster:

Complete the form to request a copy of our research poster.

    Keep me up to date with the latest news and events.

    References for our poster:

    1. Mtech Access. Market access stakeholders and processes for medical devices in key European markets and the USA. 2nd Edition. Available from: https://mtechaccess.co.uk/medtech-market-access-europe/. Accessed: October 2024.
    2. Sertkaya A, DeVries R, Jessup A, Beleche T. Estimated Cost of Developing a Therapeutic Complex Medical Device in the US. JAMA Netw Open. 2022;5(9).
    3. York Health Economics Consortium. Coverage with Evidence Development. Available from: https://yhec.co.uk/glossary/coverage-with-evidence-development. Accessed: October 2024.
    4. ISPOR. Accelerating Access to Medical Technologies: An Overview of the NICE Early Value Assessment Pilot Project in the UK. 2023. Available from: https://www.ispor.org/docs/default-source/euro2023/isporeurope23sohta186poster130461-pdf.pdf?sfvrsn=574bdf0b_0. Accessed: October 2024.
    5. NICE. Early Value Assessment (EVA) for medtech. Available from: https://www.nice.org.uk/about/what-we-do/eva-for-medtech#:~:text=EVA%20aims%20to%20support%20issues,that%20benefit%20from%20digital%20innovation. Accessed: October 2024.
    6. NICE. Early value assessment interim statement 2022. Available from: https://www.nice.org.uk/process/pmg39/resources/early-value-assessment-interim-statement-pdf-72286784283589. Accessed: October 2024.
    7. NICE. Early Value Assessment Programme: Early value assessment guidance consultation document. 2023. Available from: https://www.nice.org.uk/guidance/gid-hte10021/documents/draft-guidance#:~:text=Early%20value%20assessment%20(EVA)%20guidance,to%20address%20national%20unmet%20need. Accessed: October 2024.
    8. HAS. Innovation funding: HAS assessment principles. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2021-10/forfait_innovation_guide_principe_evaluation.pdf. Accessed: October 2024.
    9. HAS. Search for a guideline. Available from: https://www.has-sante.fr/jcms/p_3135026/en/search-for-a-guideline-an-assesment. Accessed: October 2024.
    10. G-BA. Studies to test new examination and treatment methods. Available from: https://www.g-ba.de/studien/erprobung/. Accessed: October 2024.
    11. G-BA. Testing new examination and treatment methods. Available from: https://www.g-ba.de/themen/methodenbewertung/bewertung-erprobung/erprobungsregelung/. Accessed: October 2024.
    12. Canclini EM. Los estudios de monitorización del Sistema Nacional de Salud premiados a nivel internacional. 2023. Available from: https://enotas.astursalud.es/-/los-estudios-de-monitorizaci%C3%B3n-del-sistema-nacional-de-salud-premiados-a-nivel-internacional. Accessed: October 2024.
    13. Federici C, et al. Coverage with evidence development schemes for medical devices in Europe: characteristics and challenges. Eur J Health Econ. 2021;22(8):1253-73.
    14. Ministerio de Sanidad. Instruction document of the Spanish Agency of Medicines and Medical Devices for conducting clinical trials in Spain. 2021. Available from: https://www.aemps.gob.es/investigacionClinica/medicamentos/docs/Instrucciones-realizacion-ensayos-clinicos-EN.pdf?x19374. Accessed: October 2024.
    15. ISCIII. Monitoring Studies. Available from: https://www.isciii.es/QuienesSomos/CentrosPropios/AETS/EvaluacionTecnologiasSanitarias/Paginas/Estudios-de-monitorizaci%c3%b3n.aspx. Accessed: October 2024.
    16. Serrano-Aguilar P, et al. Postlaunch evidence-generation studies for medical devices in Spain: the RedETS approach to integrate real-world evidence into decision making. International Journal of Technology Assessment in Health Care. 2021;37(1).
    17. CMS. Fact Sheet: Notice with Comment – Transitional Coverage for Emerging Technologies (CMS-3421-NC). Available from: https://www.cms.gov/newsroom/fact-sheets/notice-comment-transitional-coverage-emerging-technologies-cms-3421-nc. Accessed: October 2024.
    18. Federal Register. Medicare Program; Transitional Coverage for Emerging Technologies. 2023. Available from: https://www.govinfo.gov/content/pkg/FR-2023-06-27/pdf/2023-13544.pdf. Accessed: October 2024.